Pazopanib: retinal detachment.
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D006801:Humans; D007191:Indazoles; D061214:Patient Safety; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012163:Retinal Detachment / Q000139:chemically induced* / Q000175:diagnosis; D018570:Risk Assessment; D012307:Risk Factors; D013449:Sulfonamides / Q000009:adverse effects*
D020533:Angiogenesis Inhibitors; D007191:Indazoles; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib